We assign Siegfried a Medium Morningstar Uncertainty Rating. Its business is relatively stable, with high switching costs and good visibility due to long-term customer contracts. However, small ...

USDA Animal and Plant Health Inspection Service (APHIS) announced on January 23, 2025, that it is reinstating its legacy ...

Altimmune's existence depends almost entirely on the outcome of the Phase 2 trial for pemvidutide in MASH. Learn why ALT ...

Using 2023 as the baseline year, GenScript has developed a scientifically sound carbon reduction roadmap in accordance with SBTi requirements.

In today’s interconnected world, the spread of pathogenic microorganisms poses a significant challenge to global public ...

Vistagen Therapeutics, Inc.'s fasedienol shows promise in treating social anxiety; new results expected 2025. Click for my ...

Bio-Rad has entered a binding offer to purchase all equity interests in French biotech Stilla Technologies. According to ...

Kilroy Realty has opened a second phase of its Oyster Point life sciences campus — but it's attracting financial and tech ...

The next phase of Kilroy's big Oyster Point project is seeing interest from tech and financial services as well as biotech, long the dominant industry in South San Francisco.

LYON, France, Feb. 11, 2025 /CNW/ -- Ziwig, a French biotech company committed to advancing women's health, announces the ...

HongShan Capital Group —one of the largest private Chinese players with USD 55 billion under management, and a backer of fast ...